These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

397 related items for PubMed ID: 18281558

  • 1. Tumor-selective replication of an oncolytic adenovirus carrying oct-3/4 response elements in murine metastatic bladder cancer models.
    Wu CL, Shieh GS, Chang CC, Yo YT, Su CH, Chang MY, Huang YH, Wu P, Shiau AL.
    Clin Cancer Res; 2008 Feb 15; 14(4):1228-38. PubMed ID: 18281558
    [Abstract] [Full Text] [Related]

  • 2. Increased safety with preserved antitumoral efficacy on hepatocellular carcinoma with dual-regulated oncolytic adenovirus.
    Zhang Q, Chen G, Peng L, Wang X, Yang Y, Liu C, Shi W, Su C, Wu H, Liu X, Wu M, Qian Q.
    Clin Cancer Res; 2006 Nov 01; 12(21):6523-31. PubMed ID: 17085667
    [Abstract] [Full Text] [Related]

  • 3. A simplified system for generating oncolytic adenovirus vector carrying one or two transgenes.
    Hu ZB, Wu CT, Wang H, Zhang QW, Wang L, Wang RL, Lu ZZ, Wang LS.
    Cancer Gene Ther; 2008 Mar 01; 15(3):173-82. PubMed ID: 18157145
    [Abstract] [Full Text] [Related]

  • 4. A survivin-mediated oncolytic adenovirus induces non-apoptotic cell death in lung cancer cells and shows antitumoral potential in vivo.
    Li B, Liu X, Fan J, Qi R, Bo L, Gu J, Qian Q, Qian C, Liu X.
    J Gene Med; 2006 Oct 01; 8(10):1232-42. PubMed ID: 16900558
    [Abstract] [Full Text] [Related]

  • 5. CG0070, a conditionally replicating granulocyte macrophage colony-stimulating factor--armed oncolytic adenovirus for the treatment of bladder cancer.
    Ramesh N, Ge Y, Ennist DL, Zhu M, Mina M, Ganesh S, Reddy PS, Yu DC.
    Clin Cancer Res; 2006 Jan 01; 12(1):305-13. PubMed ID: 16397056
    [Abstract] [Full Text] [Related]

  • 6. Short hairpin RNA-expressing oncolytic adenovirus-mediated inhibition of IL-8: effects on antiangiogenesis and tumor growth inhibition.
    Yoo JY, Kim JH, Kim J, Huang JH, Zhang SN, Kang YA, Kim H, Yun CO.
    Gene Ther; 2008 May 01; 15(9):635-51. PubMed ID: 18273054
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Concurrent delivery of GM-CSF and B7-1 using an oncolytic adenovirus elicits potent antitumor effect.
    Choi KJ, Kim JH, Lee YS, Kim J, Suh BS, Kim H, Cho S, Sohn JH, Kim GE, Yun CO.
    Gene Ther; 2006 Jul 01; 13(13):1010-20. PubMed ID: 16525479
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Functional interactions of antiapoptotic proteins and tumor necrosis factor in the context of a replication-competent adenovirus.
    Liu TC, Wang Y, Hallden G, Brooks G, Francis J, Lemoine NR, Kirn D.
    Gene Ther; 2005 Sep 01; 12(17):1333-46. PubMed ID: 15920462
    [Abstract] [Full Text] [Related]

  • 12. A novel triple-regulated oncolytic adenovirus carrying PDCD5 gene exerts potent antitumor efficacy on common human leukemic cell lines.
    Xie M, Niu JH, Chang Y, Qian QJ, Wu HP, Li LF, Zhang Y, Li JL, Huang XJ, Ruan GR.
    Apoptosis; 2009 Sep 01; 14(9):1086-94. PubMed ID: 19551515
    [Abstract] [Full Text] [Related]

  • 13. Gene-viral cancer therapy using dual-regulated oncolytic adenovirus with antiangiogenesis gene for increased efficacy.
    Su C, Na M, Chen J, Wang X, Liu Y, Wang W, Zhang Q, Li L, Long J, Liu X, Wu M, Fan X, Qian Q.
    Mol Cancer Res; 2008 Apr 01; 6(4):568-75. PubMed ID: 18344493
    [Abstract] [Full Text] [Related]

  • 14. A cox-2 promoter-based replication-selective adenoviral vector to target the cox-2-expressing human bladder cancer cells.
    Shirakawa T, Hamada K, Zhang Z, Okada H, Tagawa M, Kamidono S, Kawabata M, Gotoh A.
    Clin Cancer Res; 2004 Jul 01; 10(13):4342-8. PubMed ID: 15240520
    [Abstract] [Full Text] [Related]

  • 15. Adenovirus-based virotherapy enabled by cellular YB-1 expression in vitro and in vivo.
    Rognoni E, Widmaier M, Haczek C, Mantwill K, Holzmüller R, Gansbacher B, Kolk A, Schuster T, Schmid RM, Saur D, Kaszubiak A, Lage H, Holm PS.
    Cancer Gene Ther; 2009 Oct 01; 16(10):753-63. PubMed ID: 19363467
    [Abstract] [Full Text] [Related]

  • 16. Oncolytic viral therapy by bladder instillation using an E1A, E1B double-restricted adenovirus in an orthotopic bladder cancer model.
    Wang H, Satoh M, Abe H, Sunamura M, Moriya T, Ishidoya S, Saito S, Hamada H, Arai Y.
    Urology; 2006 Sep 01; 68(3):674-81. PubMed ID: 16979729
    [Abstract] [Full Text] [Related]

  • 17. [Cytotoxic effect of oncolytic virus combined with mitomycin against human bladder cancer cells in vitro and in vivo].
    Zhao GZ, Tan WL, Zheng SB, Wu YD, Xie Y, Zhu WH.
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Nov 01; 26(11):1623-5, 1628. PubMed ID: 17121717
    [Abstract] [Full Text] [Related]

  • 18. Luciferase imaging for evaluation of oncolytic adenovirus replication in vivo.
    Guse K, Dias JD, Bauerschmitz GJ, Hakkarainen T, Aavik E, Ranki T, Pisto T, Särkioja M, Desmond RA, Kanerva A, Hemminki A.
    Gene Ther; 2007 Jun 01; 14(11):902-11. PubMed ID: 17377596
    [Abstract] [Full Text] [Related]

  • 19. An armed oncolytic adenovirus ZD55-IL-24 combined with ADM or DDP demonstrated enhanced antitumor effect in lung cancer.
    Zhong S, Yu D, Wang Y, Qiu S, Wu S, Liu XY.
    Acta Oncol; 2010 Jun 01; 49(1):91-9. PubMed ID: 19734998
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.